Sharechat Logo

What is 'Shareholder Rate Of Return'?

Friday 8th December 2000

Text too small?
A single, composite measure is required to combine growth in share price with dividends and other returns. This is the purpose of the Shareholder Rate Of Return (SROR). It is defined as the annualised total return to shareholders from maintaining their investment in a stock over a period. Maintaining the investment means neither taking any net cash out nor putting any net cash in to the stock during the period. This involves immediately re-investing all cash receipts, eg, from dividends, and participating in all capital transactions, eg, rights issues. Stock is sold as required in a rights issue so as not to contribute any net new capital.

Below is a simple example of how the SROR would be calculated for a $1000 investment over a one-year period:

Original investment$1000
+ Dividends received$40
+ Imputation credits$10
+ Price appreciation$50
= End value of investment$1100
SROR:
= change in value ÷ original value
= (1,100 - 1,000) ÷ 1,00010%

In general terms, higher rates of return indicate better performance. But, consideration must also be given to the risk profile of companies when comparing their relative performance. Naturally, investors expect a higher rate of return from companies with higher levels of risk. For example, they will have different expectations for returns from a start-up software company compared to a long-standing producer of staple food products.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report